Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events

Hepato-Gastroenterology

Volumn 50, Issue 49, 2003, Pages 132-135

  Papa, Alfredo ^a   Danese, Silvio ^b   Piccirillo, Nicola ^b   Toriani Terenzi, Caterina ^b   Bartolozzi, Francesco ^b   Piscaglia, Anna Chiara ^b   Grillo, Antonino ^b   Leone, Giuseppe ^b   Gentiloni Silveri, Nicoló ^b   Gasbarrini, Giovanni ^b   Gasbarrini, Antonio ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b NONE

Author keywords

Crohn's disease; Inflammatory bowel disease; Thrombopoietin; Thrombosis; Ulcerative colitis

Indexed keywords

THROMBOPOIETIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; DISEASE ACTIVITY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; MESENTERIC BLOOD VESSEL OCCLUSION; PATHOGENESIS; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTOPOIESIS; THROMBOCYTOSIS; THROMBOEMBOLISM; ULCERATIVE COLITIS;

ADULT; AGED; AGED, 80 AND OVER; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM; THROMBOPOIETIN;

EID: 0037263246     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Talbot RW, Heppell J, Dozois RR, Beart RW: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986; 61:140-145.
2. Wakefield AJ, Sawyerr AM, Dhillon AP, Pittilo RM, Rowles PM, Lewis AA, Pounder RE: Pathogenesis of Crohn's disease: multifocal intestinal infarction. Lancet 1989; 2:1057-1062.
3. Chiarantini E, Valanzano R, Liotta AA, Cellai AP, Fedi S, Ilari I, Prosco D, Tonelli F, Abbate R: Hemostatic abnormalities in inflammatory bowel disease. Thromb Res 1996; 82:137-146.
4. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzales D, Fontcuberta J: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995; 40:1883-1889.
5. Collins CE, Rampton DS: Platelets dysfunction: a new dimension in inflammatory bowel disease. Gut 1995; 36:5-8.
6. Harries AD, Fitzsimons E, Fifield R, Dew MJ, Rhodes J: Platelet count: a simple measure of activity in Crohn's disease. Br Med J 1983; 286:1476.
7. Kashansky K: Thrombopoietin. N Engl J Med 1998; 339:746-754.
8. Kapsoritakis AN, Potamionos SP, Sfiridaki AI, Koukourakis MI, Koutroubakis IE, Roussomoustakaki MI, Manousos ON, Kouroumalis EA: Elevated thrombopoietin serum levels in patients with inflammatory bowel disease. Am J Gastroenterol 2000; 95:3478-3481.
9. Heits F, Stahl M, Stange EF, Jelkmann W: Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease. J Interferon Cytokine Res 1999; 19:757-760.
10. Bernestein CN, Blanchard JF, Houston DS, Wajda A: The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost 2001; 85:430-434.
11. Grip O, Svensson PJ, Lindgren S: Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35:619-623.
12. Papa A, Danese S, Gasbarrini A, Gasbarrini G: Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14:1403-1409.
13. Papa A, De Stefano V, Gasbarrini A, Chiusolo P, Cianci R, Casorelli I, Paciaroni K, Cammarota G, Leone G, Gasbarrini G: Prevalence of factor V Leiden and the G20210A prothrombin-gene mutation in inflammatory bowel disease. Blood Coagul Fibrinolysis 2000; 11:499-503.
14. Papa A, De Stefano V, Danese S, Chiusolo P, Persichilli S, Casorelli I, Zappacosta B, Giardina B, Gasbarrini A, Leone G, Gasbarrini G: Hyperhomocysteinemia and prevalence of polymorphisms of homocysteine metabolism related enzymes in patients with inflammatory bowel disease. Am J Gastroenterol 2001, 96:2677-2682.
15. Carty E, Macey M, Rampton DS: Inhibition of platelet activation by 5-aminosalicylic acid in inflammatory bowel disease. Aliment Pharmacol Ther 2000; 14:1169-1179.
16. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamionos SP, Kosmadaki MG, Koutroubakis IE, Kouroumalis EA: Mean Platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96:776-781.
17. Chen J, Herceg-Harjacek L, Groopman JE, Grabarek J: Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 1995; 86:4054-4062.
18. Kaser A, Brandacher G, Steurer W, Kaser S, Offner FA, Zoller H, Theurl I, Wider W, Molnar C, Ludwiczek O, Atkins MB, Mier JW, Tilg H: Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001; 98:2720-2725.